Lyme borreliosis

Lancet

Volumn 352, Issue 9127, 1998, Pages 557-565

  Nadelman, Robert B ^a   Wormser, Gary P ^a  

^a WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; DOXYCYCLINE; PENICILLIN G; PENICILLIN V; TETRACYCLINE;

ADULT; BORRELIA BURGDORFERI; CHILD; CLINICAL FEATURE; CLINICAL OBSERVATION; DERMATITIS; ERYTHEMA CHRONICUM MIGRANS; EUROPE; FEMALE; HUMAN; LABORATORY; LABORATORY TEST; LYME DISEASE; MALE; NEUROLOGIC DISEASE; NORTH AMERICA; PATHOGENICITY; PRIORITY JOURNAL; PROTEUS; REVIEW; TICK;

EID: 0032529518     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)01146-5     Document Type: Review

References (47)

1. 1 Kurtenbach K, Sewell H-S, Ogden NH, Randolph SE, Nuttall PA. Serum complement sensitivity as a key factor in Lyme disease ecology. Infect Immun 1998; 66: 1248-51.
2. 2 Fish D. Environmental risk and prevention of Lyme disease. Am J Med 1995; 98: 2S-7S.
3. 3 Gern L, Burgdorfer W, Aeschlimann A, Krampitz HE. The ecology of Lyme borreliosis in Europe. In: Weber K, Burgdorfer W, Schierz G, eds. Aspects of Lyme borreliosis. Berlin: Springer-Verlag, 1993: 59-69.
4. 4 Steere AC. Lyme Disease. N Engl J Med 1989; 321: 586-96.
5. 5 Anon. Case definitions for infectious conditions under public health surveillance: Lyme disease (revised 9/96). MMWR 1997; 46 (suppl RR-10) 20-21.
6. 6 Stanek G, O'Connell S, Cimmino M, et al. European Union concerted action on risk assessment in Lyme borreliosis: clinical case definition for Lyme borreliosis. Wien Klin Wochenschr 1996; 108: 741-47.
7. 7 Anon. Recommendations for test performance and interpetation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR 1995; 44: 590-91.
8. 8 Tugwell P, Dennis DT, Weinstein A, et al. Clinical guideline 2: laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997; 127: 1109-23.
9. 9 Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase PW, Andiman WA. Erythema migrans and Lyme arthritis: the enlarging clinical spectrum. Ann Intern Med 1977; 86: 685-98.
10. 10 Åsbrink E, Olsson I, Novmark A. Erythema chronicum migrans Afzelius in Sweden: a study on 231 patients. Zbl Bakt Hyg A 1986; 263: 229-36.
11. 11 Nadelman RB, Nowakowski J, Forseter G, et al. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med 1996; 100: 502-08.
12. 12 Strle F, Nadelman RB, Cimperman J, et al. Comparison of culture-confirmed erythema migrans in Europe and the United States. Unpublished.
13. 13 Picken RN, Strle F, Ruzic-Sabljic E, et al. Molecular subtyping of Borrelia burgdorferi sensu lato isolates from five patients with solitary lymphocytoma. J Invest Dermatol 1997; 108: 92-97.
14. 14 van der Linde MR, Ballmer PE. Lyme carditis. In: Weber K, Burgdorfer W, Schierz G, eds. Aspects of Lyme borreliosis. Berlin: Springer-Verlag, 1993: 131-45.
15. 15 Krüger H, Kohlhepp W, König S. Follow-up of antibiotically treated and untreated neuroborreliosis. Acta Neurol Scand 1990; 82: 59-67.
16. 16 Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990; 323: 1438-44.
17. 17 Halperin JJ, Logigian EL, Finkel MF, Pearl RA. Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Neurology 1996; 46: 619-27.
18. 18 Karlsson M, Hammers-Berggren S, Lindquist L, Stiernstedt G, Svenungsson B. Comparison of intravenous penicillin G and oral doxycyline for treatment of Lyme neuroborreliosis. Neurology 1994; 44: 1203-07.
19. 19 Steere AC, Levin RE, Molloy PJ, et al. Treatment of Lyme arthritis. Arthr Rheum 1994; 37: 877-88.
20. 20 Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994; 330: 229-34.
21. 21 Steere AC, Schoen R, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med 1987; 107: 725-31.
22. 22 Gerber MA, Shapiro ED, Burke GS, et al. Lyme disease in children in southeastern Connecticut. N Engl J Med 1996; 335: 1270-74.
23. 23 van Dam VP, Kuiper H, Vos K, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 1993; 17: 708-17.
24. 24 Krause PJ, Telford SR III, Spielman A, et al. Concurrent Lyme disease and babesiosis: evidence for increased severity and duration of illness. JAMA 1996; 275: 1657-60.
25. 25 Nadelman RB, Horowitz HW, Hsieh T-C, et al. Simultaneous human ehrlichiosis and Lyme borreliosis. N Engl J Med 1997; 337: 27-30.
26. 26 Kirkland KB, Klimko TB, Meriwether RA, et al. Erythema migrans-like rash illness at a camp in North Carolina: a new tick-borne disease? Arch Intern Med 1997; 157: 2635-41.
27. 27 State of Connecticut Department of Public Health. Lyme disease update. Conn Epidemiol 1993; 13: 9.
28. 28 Stanek G, Klein J, Bittner R, Dietmar G. Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med 1990; 322: 249-52.
29. 29 Sonnesyn SW, Diehl SC, Johnson RC, Kubo SH, Goodman JL. A prospective study of the seroprevalence of Borrelia burgdorferi infection in patients with severe heart failure. Am J Cardiol 1995; 76: 97-100.
30. 30 Wormser GP. Treatment and prevention of Lyme disease, with emphasis on antimicrobial therapy for neuroborreliosis and vaccination. Semin Neurol 1997; 17: 45-52.
31. 31 Nadelman RB, Herman E, Wormser GP. Screening for Lyme disease in hospitalized psychiatric patients: prospective serosurvey in an endemic area. Mt Sinai J Med 1997; 64: 409-12.
32. 32 Maraspin V, Cimperman J, Lotrič-Furlan, Pleterski-Rigler D, Strle F. Treatment of erythema migrans in pregnancy. Clin Infect Dis 1996; 22: 788-93.
33. 33 Dattwyler RJ, Luft BJ, Maladorno D, et al. Treatment of late Lyme disease - a comparison of 2 weeks vs 4 weeks of ceftriaxone. In: Proceedings of the Seventh International Congress on Lyme Borreliosis (San Francisco, June 16-21, 1996): 662 (abstr).
34. 34 Luft BJ, Dattwyler RJ, Johnson RC, et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans: a double-blind, randomized, controlled trial. Ann Intern Med 1996; 124: 785-91.
35. 35 Warshafsky S, Nowakowski J, Nadelman RB, Kamer RS, Peterson SJ. Wormser GP. Efficacy of antibiotic prophylaxis for prevention of Lyme disease. J Gen Intern Med 1996; 11: 329-33.
36. 36 Berger BW, Johnson RC, Kodner C, Coleman L. Failure of Borrelia burgdorferi to survive in the skin of patients with antibiotic-treated Lyme disease. J Am Acad Dematol 1992; 27: 34-37.
37. 37 Nadelman RB, Nowakowski J, Forseter G, et al. Failure to isolate Borrelia burgdorferi after antimicrobial therapy in culture-documented Lyme borreliosis associated with erythema migrans: report of a prospective study. Am J Med 1993; 94: 583-88.
38. 38 Preac-Mursic V, Weber K, Pfister HW, et al. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borrelioss. Infection 1989; 17: 355-59.
39. 39 Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA 1993; 269: 1812-16.
40. 40 Telford SR III, Armstrong PM, Katovolos P, et al. A new tick-borne encephalitis-like virus infecting New England deer ticks, Ixodes dammini. Emerging Infect Dis 1997; 3: 165-70.
41. 41 Seltzer EG, Shapiro ED, Gerber MA, Cartter ML. Long-term outcomes of persons with Lyme disease. Clin Infect Dis 1997; 25: 361 (abstr 36).
42. 42 Ettestad PJ, Campbell GL, Welbel SF, et al. Biliary complications in the treatment of unsubstantiated Lyme disease. J Infect Dis 1995; 171: 356-61.
43. 43 Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia Burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med 1998; 339: 209-15.
44. 44 Sigal LH, Zahradnik JM, Lavin P, et al. A vaccine consisting of recombinant Borelia burgdorferi outer-surface protein A to prevent lyme disease. N Engl J Med 1998; 339: 216-22.
45. 45 de Silva AM, Fikrig E. Arthropod-and host-specific gene expression by Borrelia burgdorferi. J Clin Invest 1997; 94: 377-79.
46. 46 Fraser CM, Casjens S, Huang WM, et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997; 390: 580-86.
47. 47 Schwan TG, Piesman J, Golde WT, Dolan MC, Rosa PA. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci USA 1995; 92: 2909-13.